Relapsing fever borrelioses: Forgotten and new ones

Terapevticheskii Arkhiv

Volumn 82, Issue 11, 2010, Pages 74-80

  Platonov, A E ^a   Maleyev, V V ^a   Karan, L S ^a  

^a CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

Author keywords

Borrelia miyamotoi; Borreliosis; Clinical manifestations; Pathogenesis; Tick borne relapsing fevers; Treatment

Indexed keywords

BORRELIA; BORRELIA INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; REVIEW;

BORRELIA; HUMANS; RELAPSING FEVER;

EID: 78651486908     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Tilly K., Rosa P. A., Stewart P. E. Biology of infection with Borrelia burgdorferi. Infect. Dis. Clin. N. Am. 2008; 22(2): 217-234.
2. Barbour A. G., Hayes S. F. Biology of Borrelia species. Microbiol. Rev. 1986; 50(4): 381-400.
3. Tsao J. I. Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles. Vet. Res. 2009; 40(2): 36.
4. Margos G., Gatewood A. G., Aanensen D. M. et al. MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 2008; 105(25): 8730-8735.
5. Fukunaga M., Okada K., Nakao M. et al. Phylogenetic analysis of Borrelia species based on flagellin gene sequences and its application for molecular typing of Lyme disease borreliae. Int. J. Syst. Bacteriol. 1996; 46(4): 898-905.
6. Warrel D. A., Parry E. H. O. Relapsing fever. In: Cohen J., Powderly W. G., eds. Infectious diseases. Edinburgh: Elsevier; 2004. 1671-1674.
7. Cutler S. J. Possibilities for relapsing fever reemergence. Emerg. Infect. Dis. 2006; 12(3): 369-374.
8. Larsson C., Andersson M., Bergstrom S. Current issues in relapsing fever. Curr. Opin. Infect. Dis. 2009; 22(5): 443-449.
9. Dworkin M. S., Schwan T. G., Anderson D. E., Borchardt S. M. Tick-borne relapsing fever. Infect. Dis. Clin. N. Am. 2008; 22(3): 449-468.
10. Assous M. V., Wilamowski A. Relapsing fever borreliosis in Eurasia -forgotten, but certainly not gone! Clin. Microbiol. Infect. 2009; 15(5): 407-414.
11. Masters E. J., Grigery C. N., Masters R. W. STARI, or Masters disease: Lone Star tickvectored Lyme-like illness. Infect. Dis. Clin. N. Am. 2008; 22(2): 361-376.
12. Barbour A. G., Bunikis J., Travinsky B. et al. Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species. Am. J. Trop. Med. Hyg. 2009; 81(6): 1120-1131.
13. Nordstrand A., Bunikis I., Larsson C. et al. Tickborne relapsing fever diagnosis obscured by malaria, Togo, Emerg. Infect. Dis. 2007; 13(1): 117-123.
14. Glockner G., Lehmann R., Romualdi A. et al. Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res. 2004; 32(20): 6038-6046.
15. Lescot M., Audic S., Robert C. et al. The genome of Borrelia recurrentis, the Agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PloS Genet. 2008; 4 (9): e1000185.
16. Vial L., Diana G., Tall A. et al. Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet 2006; 368 (9529): 37-43.
17. Sarih M., Gamier M., Boudebouch N. et al. Borrelia hispanica relapsing fever, Morocco. Emerg. Infect. Dis. 2009; 15(10): 1626-1629.
18. Masoumi A. H., Goya M. M., Vatandoost H. et al. The epidemiology of tick-borne relapsing fever in Iran during 1997- 2006. Travel Med, Infect. Dis. 2009; 7(3): 160-164.
19. Dunham-Ems S. M., Caimano M. J., Pal U. et al. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J. Clin. Invest. 2009; 119(12): 3652-3665.
20. Gem L. Life cycle of Borrelia burgdorferi sensu lato and transmission to humans. Curr. Probl. Dermatol. 2009; 37: 18-30.
21. Norman M. U., Moriarty T. J., Dresser A. R. et al. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 2008; 4(10): e1000169.
22. Schott M., Grosskinsky S., Brenner C. et al. Molecular characterization of the interaction of Borrelia parken and Borrelia turicatae with human complement regulators. Infect, and Immun. 2010; 78(5): 2199-2208.
23. Cabello F. C., Godfrey H. P., Newman S. A. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 2007; 15(8): 350-354.
24. Barbour A. G., Dai Q., Restrepo B. I. et al. Pathogen escape from host immunity by a genome program for antigenic variation. Proc. Natl. Acad. Sci. USA 2006; 103(48): 18290-18295.
25. Roscoe C., Epperly T. Tick-borne relapsing fever. Am. Fam. Physician 2005; 72 (10): 2039-2044.
26. Cadavid D., Londono D. Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes. Clin. Microbiol. Infect. 2009; 15(5): 415-421.
27. Acute respiratory distress syndrome in persons with tickborne relapsing fever -three states, 2004-2005. Morbid. Mortal. Wkly Rep. 2007; 56(41): 1073-1076.
28. Larsson C,, Lundqvist J., van Rooijen N., Bergstrom S. A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice. PLoS Negl. Trop. Dis. 2009; 3(9): e522.
29. Colombo M. J., Alugupalli K. R. Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J. Immunol. 2008; 180(7): 4858-4864.
30. Hamase A., Takahashi Y., Nohgi K., Fukunaga M. Homology of variable major protein genes between Borrelia hermsii and Borrelia miyamotoi. FEMS Microbiol. Lett. 1996; 140(2-3): 131-137.
31. Guyard C., Battisti J. M., Raffel S. J. et al. Relapsing fever spirochaetes produce a serine protease that provides resistance to oxidative stress and killing by neutrophils. Mol. Microbiol. 2006; 60(3): 710-722.
32. Woodman M. E., Cooley A. E., Avdiushko R. et al. Roles for phagocytic cells and complement in controlling relapsing fever infection. J. Leukoc. Biol. 2009; 86(3): 727-736.
33. Guo B. P., Teneberg S., Munch R. et al. Relapsing fever Borrelia binds to neolacto glycans and mediates resetting of human erythrocytes. Proc. Natl. Acad. Sci. USA 2009; 106(46): 19280-19285.
34. Scragg I. G., Kwiatkowski D., Vidal V. et al. Structural characterization of the inflammatory moiety of a variable major lipoprotein of Borrelia recurrentis. J. Biol. Chem. 2000; 275 (2): 937-941.
35. Hardy P. H. Jr., Levin J. Lack of endotoxin in Borrelia hispánica and Treponema pallidum. Proc. Soc. Exp. Biol. (N. Y.) 1983; 174(1): 47-52.
36. Negussie Y., Remick D. G., DeForge L. E. et al. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J. Exp. Med. 1992; 175 (5): 1207-1212.
37. van Dam A. P., van Goal T., Wetsteyn J. C., Dankert J. Tickborne relapsing fever imported from West Africa: diagnosis by quantitative bufry coat analysis and in vitro culture of Borrelia crocidurae. J. Clin. Microbiol. 1999; 37(6): 2027-2030.
38. Lopez J. E., Porcella S. F., Schrumpf M. E. et al. Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia. Microbiology 2009; 155(8): 2641-2651.
39. Hasin T., Davidovitch N., Cohen R. et. al. Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N. Engl. J. Med. 2006; 355(2): 148-155.
40. Porcella S. F., Raffel S. J., Schrumpf M. E. et al. Serodiagnosis of louse-borne relapsing fever with glycerophosphodiester phosphodiesterase (G1pQ) from Borrelia recurrentis. J. Clin. Microbiol. 2000; 38(10): 3561-3571.
41. Halperin T., Orr N., Cohen R. et al. Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Trop. 2006; 98(2): 189-195.
42. Swanson S. J., Neitzel D., Reed K. D., Belongia E. A. Coinfections acquired from ixodes ticks. Clin. Microbiol. Rev. 2006; 19 (4): 708-727.